Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Multi-center, Randomized, Subject/Evaluator Blind, Active-controlled, Non-inferiority Pivotal Clinical Study to Compare the Efficacy and Safety of Collabarrier® With Guardix-sol for the Prevention of Postoperative Adhesion After Operation for Disc Herniation or Spinal Stenosis

NCT07153822 is registered in ClinicalTrials.gov with DALIM TISSEN Co., Ltd. as lead sponsor.

NCT NCT07153822
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07153822 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Multi-center, Randomized, Subject/Evaluator Blind, Active-controlled, Non-inferiority Pivotal Clinical Study to Compare the Efficacy and Safety of Collabarrier® With Guardix-sol for the Prevention of Postoperative Adhesion After Operation for Disc Herniation or Spinal Stenosis
Lead sponsor
DALIM TISSEN Co., Ltd.
Phase
Not applicable
Overall status
Completed
Start date
December 15, 2022
Completion date
January 29, 2024
Enrollment
69 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

epidural fibrosis, lumbar disc herniation, lumbar spinal stenosis, postoperative adhesion